AAAAAA

   
Results: 1-25 | 26-50 |
Results: 26-50/50
ANTIBODY-RESPONSES TO POLYSACCHARIDE AND POLYSACCHARIDE-CONJUGATE VACCINES AFTER TREATMENT OF HODGKIN DISEASE
Authors: MOLRINE DC GEORGE S TARBELL N MAUCH P DILLER L NEUBERG D SHAMBERGER RC ANDERSON EL PHILLIPS NR KINSELLA K AMBROSINO DM
Citation: Dc. Molrine et al., ANTIBODY-RESPONSES TO POLYSACCHARIDE AND POLYSACCHARIDE-CONJUGATE VACCINES AFTER TREATMENT OF HODGKIN DISEASE, Annals of internal medicine, 123(11), 1995, pp. 828
MYELODYSPLASTIC SYNDROME AS A LATE COMPLICATION FOLLOWING AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR NON-HODGKINS-LYMPHOMA
Authors: STONE RM NEUBERG D SOIFFER R TAKVORIAN T WHELAN M RABINOWE SN ASTER JC LEAVITT P MAUCH P FREEDMAN AS NADLER LM
Citation: Rm. Stone et al., MYELODYSPLASTIC SYNDROME AS A LATE COMPLICATION FOLLOWING AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR NON-HODGKINS-LYMPHOMA, Journal of clinical oncology, 12(12), 1994, pp. 2535-2542
SYNERGISTIC EFFECTS OF INTERLEUKIN-11 WITH OTHER GROWTH-FACTORS ON THE EXPANSION OF MURINE HEMATOPOIETIC PROGENITORS AND MAINTENANCE OF STEM-CELLS IN LIQUID CULTURE
Authors: NEBEN S DONALDSON D SIEFF C MAUCH P BODINE D FERRARA J YETZALDAPE J TURNER K
Citation: S. Neben et al., SYNERGISTIC EFFECTS OF INTERLEUKIN-11 WITH OTHER GROWTH-FACTORS ON THE EXPANSION OF MURINE HEMATOPOIETIC PROGENITORS AND MAINTENANCE OF STEM-CELLS IN LIQUID CULTURE, Experimental hematology, 22(4), 1994, pp. 353-359
ANTIBODY-RESPONSE TO POLYSACCHARIDE (PS)-CONJUGATE VACCINES FOLLOWINGTREATMENT FOR HODGKINS-DISEASE
Authors: MOLRINE D GEORGE S TARBELL N MAUCH P DILLER L NEUBERG D SHAMBERGER R ANDERSON E PHILLIPS N KINSELLA K AMBROSINO D
Citation: D. Molrine et al., ANTIBODY-RESPONSE TO POLYSACCHARIDE (PS)-CONJUGATE VACCINES FOLLOWINGTREATMENT FOR HODGKINS-DISEASE, Pediatric research, 35(4), 1994, pp. 10000189-10000189
HISTOPATHOLOGIC GRADING OF NODULAR SCLEROSIS HODGKINS-DISEASE - LACK OF PROGNOSTIC-SIGNIFICANCE IN 254 SURGICALLY STAGED PATIENTS
Authors: HESS JL BODIS S PINKUS G SILVER B MAUCH P
Citation: Jl. Hess et al., HISTOPATHOLOGIC GRADING OF NODULAR SCLEROSIS HODGKINS-DISEASE - LACK OF PROGNOSTIC-SIGNIFICANCE IN 254 SURGICALLY STAGED PATIENTS, Cancer, 74(2), 1994, pp. 708-714
AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN RELAPSED LOW-GRADE NON-HODGKINS-LYMPHOMA
Authors: FREEDMAN A NEUBERG D GRIBBEN J MAUCH P ANDERSON K SOIFFER R PANDITE L ROBERTSON M KROON M GROVER J CORAL F RITZ J NADLER L
Citation: A. Freedman et al., AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN RELAPSED LOW-GRADE NON-HODGKINS-LYMPHOMA, Blood, 84(10), 1994, pp. 10000203-10000203
CD6-DEPLETED ALLOGENEIC BMT FOR ADULTS WITH ACUTE-LEUKEMIA
Authors: SOIFFER R MURRAY C FAIRCLOUGH D ROBERTSON M FREEDMAN A ANDERSON K PANDITE L FREEMAN A MARCUS K MAUCH P NADLER L RITZ J
Citation: R. Soiffer et al., CD6-DEPLETED ALLOGENEIC BMT FOR ADULTS WITH ACUTE-LEUKEMIA, Blood, 84(10), 1994, pp. 10000332-10000332
THE ROLE OF THE B7-1 AND B7-2 COSTIMULATORY MOLECULES IN GENERATING CELLULAR VACCINES FOR THE IMMUNOTHERAPY OF LEUKEMIA
Authors: MATULONIS U DOSIOU C LAMONT C FREEMAN GJ MAUCH P NADLER LM GRIFFIN JD
Citation: U. Matulonis et al., THE ROLE OF THE B7-1 AND B7-2 COSTIMULATORY MOLECULES IN GENERATING CELLULAR VACCINES FOR THE IMMUNOTHERAPY OF LEUKEMIA, Blood, 84(10), 1994, pp. 10000378-10000378
MDR1 GENE-EXPRESSION IN A MULTIDRUG-RESISTANT HUMAN NON-HODGKINS-LYMPHOMA XENOGRAFT MODEL
Authors: BODIS S BENARD J BOSQ J ARDOUIN P PROST S VENUAT AM DIETRICH PY RAMIREZ L MAUCH P PICO JL HAYAT M
Citation: S. Bodis et al., MDR1 GENE-EXPRESSION IN A MULTIDRUG-RESISTANT HUMAN NON-HODGKINS-LYMPHOMA XENOGRAFT MODEL, International journal of oncology, 3(1), 1993, pp. 109-114
LARGE-CELL AND IMMUNOBLASTIC LYMPHOMA OF THE MEDIASTINUM - PROGNOSTICFEATURES AND TREATMENT OUTCOME IN 57 PATIENTS
Authors: KIRN D MAUCH P SHAFFER K PINKUS G SHIPP MA KAPLAN WD TUNG N WHEELER C BEARD CJ CANELLOS GP SHULMAN LN
Citation: D. Kirn et al., LARGE-CELL AND IMMUNOBLASTIC LYMPHOMA OF THE MEDIASTINUM - PROGNOSTICFEATURES AND TREATMENT OUTCOME IN 57 PATIENTS, Journal of clinical oncology, 11(7), 1993, pp. 1336-1343
PROGNOSTIC FACTORS FOR TREATMENT OUTCOME IN AUTOTRANSPLANTATION OF INTERMEDIATE-GRADE AND HIGH-GRADE NON-HODGKINS-LYMPHOMA WITH CYCLOPHOSPHAMIDE, CARMUSTINE, AND ETOPOSIDE
Authors: WHEELER C STRAWDERMAN M AYASH L CHURCHILL WH BIERER BE ELIAS A GILLILAND DG ANTMAN K GUINAN EC EDER JP WEINSTEIN H SCHWARTZ G FERRARA J MAZANET R RIMM IJ TEPLER I MCCARTHY P MAUCH P AULT K GAYNES L MCCAULEY M SCHNIPPER LE ANTIN J
Citation: C. Wheeler et al., PROGNOSTIC FACTORS FOR TREATMENT OUTCOME IN AUTOTRANSPLANTATION OF INTERMEDIATE-GRADE AND HIGH-GRADE NON-HODGKINS-LYMPHOMA WITH CYCLOPHOSPHAMIDE, CARMUSTINE, AND ETOPOSIDE, Journal of clinical oncology, 11(6), 1993, pp. 1085-1091
AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN POOR-PROGNOSIS INTERMEDIATE-GRADE AND HIGH-GRADE B-CELL NON-HODGKINS-LYMPHOMA IN 1ST REMISSION - A PILOT-STUDY
Authors: FREEDMAN AS TAKVORIAN T NEUBERG D MAUCH P RABINOWE SN ANDERSON KC SOIFFER RJ SPECTOR N GROSSBARD M ROBERTSON MJ BLAKE K CORAL F CANELLOS GP RITZ J NADLER LM
Citation: As. Freedman et al., AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN POOR-PROGNOSIS INTERMEDIATE-GRADE AND HIGH-GRADE B-CELL NON-HODGKINS-LYMPHOMA IN 1ST REMISSION - A PILOT-STUDY, Journal of clinical oncology, 11(5), 1993, pp. 931-936
PRIMARY KI-1 ANAPLASTIC LARGE-CELL LYMPHOMA IN ADULTS - CLINICAL CHARACTERISTICS AND THERAPEUTIC OUTCOME
Authors: SHULMAN LN FRISARD B ANTIN JH WHEELER C PINKUS G MAGAURAN N MAUCH P NOBLES E MASHAL R CANELLOS G TUNG N KADIN M
Citation: Ln. Shulman et al., PRIMARY KI-1 ANAPLASTIC LARGE-CELL LYMPHOMA IN ADULTS - CLINICAL CHARACTERISTICS AND THERAPEUTIC OUTCOME, Journal of clinical oncology, 11(5), 1993, pp. 937-942
HISTOLOGIC SUBCLASSIFICATION DOES NOT PREDICT FOR OUTCOME IN PATHOLOGICALLY STAGED IA-IIIB NODULAR SCLEROSIS HODGKINS-DISEASE
Authors: BODIS S HESS J PINKUS G SILVER B MAUCH P
Citation: S. Bodis et al., HISTOLOGIC SUBCLASSIFICATION DOES NOT PREDICT FOR OUTCOME IN PATHOLOGICALLY STAGED IA-IIIB NODULAR SCLEROSIS HODGKINS-DISEASE, International journal of radiation oncology, biology, physics, 27, 1993, pp. 231-232
QUANTITATION OF MURINE HEMATOPOIETIC STEM-CELLS IN-VITRO BY LIMITING DILUTION ANALYSIS OF COBBLESTONE AREA FORMATION ON A CLONAL STROMAL CELL-LINE
Authors: NEBEN S ANKLESARIA P GREENBERGER J MAUCH P
Citation: S. Neben et al., QUANTITATION OF MURINE HEMATOPOIETIC STEM-CELLS IN-VITRO BY LIMITING DILUTION ANALYSIS OF COBBLESTONE AREA FORMATION ON A CLONAL STROMAL CELL-LINE, Experimental hematology, 21(3), 1993, pp. 438-443
HEMATOPOIETIC STEM-CELL DEFICIT OF TRANSPLANTED BONE-MARROW PREVIOUSLY EXPOSED TO CYTOTOXIC AGENTS
Authors: NEBEN S HEMMAN S MONTGOMERY M FERRARA J MAUCH P
Citation: S. Neben et al., HEMATOPOIETIC STEM-CELL DEFICIT OF TRANSPLANTED BONE-MARROW PREVIOUSLY EXPOSED TO CYTOTOXIC AGENTS, Experimental hematology, 21(1), 1993, pp. 156-162
MONOCLONAL ANTIBODY-PURGED AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN ADULTS WITH ACUTE LYMPHOBLASTIC-LEUKEMIA AT HIGH-RISK OF RELAPSE
Authors: SOIFFER RJ ROY DC GONIN R MURRAY C ANDERSON KC FREEDMAN AS RABINOWE SN ROBERTSON MJ SPECTOR N PESEK K MAUCH P NADLER LM RITZ J
Citation: Rj. Soiffer et al., MONOCLONAL ANTIBODY-PURGED AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN ADULTS WITH ACUTE LYMPHOBLASTIC-LEUKEMIA AT HIGH-RISK OF RELAPSE, Bone marrow transplantation, 12(3), 1993, pp. 243-251
SEX-DIFFERENCES IN RISK OF 2ND MALIGNANT-TUMORS AFTER HODGKINS-DISEASE IN CHILDHOOD
Authors: TARBELL NJ GELBER RD WEINSTEIN HJ MAUCH P
Citation: Nj. Tarbell et al., SEX-DIFFERENCES IN RISK OF 2ND MALIGNANT-TUMORS AFTER HODGKINS-DISEASE IN CHILDHOOD, Lancet, 341(8858), 1993, pp. 1428-1430
PROGNOSTIC FACTORS FOR PATIENTS WITH HODGKIN DISEASE IN 1ST RELAPSE -REPLY
Authors: HEALEY EA MAUCH P
Citation: Ea. Healey et P. Mauch, PROGNOSTIC FACTORS FOR PATIENTS WITH HODGKIN DISEASE IN 1ST RELAPSE -REPLY, Cancer, 72(7), 1993, pp. 2290-2291
WIDE-FIELD RADIATION-THERAPY WITH OR WITHOUT CHEMOTHERAPY FOR PATIENTS WITH HODGKIN DISEASE IN RELAPSE AFTER INITIAL COMBINATION CHEMOTHERAPY
Authors: UEMATSU M TARBELL NJ SILVER B COLEMAN CN ROSENTHAL DS SHULMAN LN CANELLOS G WEINSTEIN H MAUCH P
Citation: M. Uematsu et al., WIDE-FIELD RADIATION-THERAPY WITH OR WITHOUT CHEMOTHERAPY FOR PATIENTS WITH HODGKIN DISEASE IN RELAPSE AFTER INITIAL COMBINATION CHEMOTHERAPY, Cancer, 72(1), 1993, pp. 207-212
PEDIATRIC STAGE-IV HODGKIN DISEASE - LONG-TERM SURVIVAL
Authors: BADER SB WEINSTEIN H MAUCH P SILVER B TARBELL NJ
Citation: Sb. Bader et al., PEDIATRIC STAGE-IV HODGKIN DISEASE - LONG-TERM SURVIVAL, Cancer, 72(1), 1993, pp. 249-255
MONOCLONAL ANTIBODY-PURGED BONE-MARROW TRANSPLANTATION THERAPY FOR MULTIPLE-MYELOMA
Authors: ANDERSON KC ANDERSEN J SOIFFER R FREEDMAN AS RABINOWE SN ROBERTSON MJ SPECTOR N BLAKE K MURRAY C FREEMAN A CORAL F MARCUS KC MAUCH P NADLER LM RITZ J
Citation: Kc. Anderson et al., MONOCLONAL ANTIBODY-PURGED BONE-MARROW TRANSPLANTATION THERAPY FOR MULTIPLE-MYELOMA, Blood, 82(8), 1993, pp. 2568-2576
AUTOLOGOUS AND ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR POOR-PROGNOSIS PATIENTS WITH B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA
Authors: RABINOWE SN SOIFFER RJ GRIBBEN JG DALEY H FREEDMAN AS DALEY J PESEK K NEUBERG D PINKUS G LEAVITT PR SPECTOR NA GROSSBARD ML ANDERSON K ROBERTSON MJ MAUCH P CHAYTMARCUS K RITZ J NADLER LM
Citation: Sn. Rabinowe et al., AUTOLOGOUS AND ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR POOR-PROGNOSIS PATIENTS WITH B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA, Blood, 82(4), 1993, pp. 1366-1376
AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN ADVANCED LOW-GRADE B-CELL NON-HODGKINS-LYMPHOMA IN 1ST REMISSION
Authors: FREEDMAN A GRIBBEN J RABINOWE S NEUBERG D MAUCH P SPECTOR N ANDERSON K SOIFFER R PESEK K ROBERTSON M WHELAN M RITZ J NADLER L
Citation: A. Freedman et al., AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN ADVANCED LOW-GRADE B-CELL NON-HODGKINS-LYMPHOMA IN 1ST REMISSION, Blood, 82(10), 1993, pp. 10000332-10000332
PREVENTION OF LEUKEMIA IN IMMUNOLOGICALLY INTACT MICE BY INTRODUCTIONOF THE B7 COSTIMULATORY MOLECULE INTO A SYNGENEIC MYELOID CELL-LINE TRANSFORMED BY P210BCR ABL/
Authors: MATULONIS U MAUCH P FREEMAN G LAMONT C NADLER L GRIFFIN JD
Citation: U. Matulonis et al., PREVENTION OF LEUKEMIA IN IMMUNOLOGICALLY INTACT MICE BY INTRODUCTIONOF THE B7 COSTIMULATORY MOLECULE INTO A SYNGENEIC MYELOID CELL-LINE TRANSFORMED BY P210BCR ABL/, Blood, 82(10), 1993, pp. 10000442-10000442
Risultati: 1-25 | 26-50 |